Parkwalk Advisors has invested an undisclosed sum in Cardiff ultrasound simulation technology developer MedaPhor through its Opportunities Fund.
MedaPhor, a UK-based ultrasound simulation technology spinout from University of Cardiff, has raised an undisclosed amount from Parkwalk Advisors, the fund management division of commercialisation firm IP Group.
Parkwalk invested through its Opportunities Fund, a vehicle set up to receive tax advantages in the UK.
Founded in 2004, MedaPhor develops a range of mainly ultrasound-powered technologies for purposes including medical simulations and training.
The spinout also offers clinical ultrasound applications through Intelligent Ultrasound, which it acquired for…
